Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-10-26

FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OSPHENA (ospemifene) by Duchesnay USA, Inc., typically to modify labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osphena (ospemifene)

Snippet

SUPPL AP for OSPHENA (OSPEMIFENE)